Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,159 | -34,308 | -19,605 | -11,672 | -23,431 |
| Depreciation Amortization | 221 | 900 | 680 | 454 | 751 |
| Accounts receivable | 74 | N/A | 4 | -17 | N/A |
| Accounts payable and accrued liabilities | 37 | N/A | -1,907 | 318 | N/A |
| Other Working Capital | 32,215 | 177 | -633 | 589 | -8,267 |
| Other Operating Activity | 925 | 16 | -3,678 | -6,120 | -1,059 |
| Operating Cash Flow | $20,313 | $-33,215 | $-25,139 | $-16,448 | $-32,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 7,668 | 7,668 | N/A |
| PPE Investments | -22 | -307 | -280 | -276 | -884 |
| Other Investing Activity | 0 | 6,670 | -425 | -425 | 28,117 |
| Investing Cash Flow | $-22 | $6,363 | $6,963 | $6,967 | $27,233 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,574 | 1,570 | N/A |
| Debt Repayment | -119 | N/A | -81 | -50 | N/A |
| Common Stock Issued | 564 | N/A | 160 | 21 | N/A |
| Other Financing Activity | 109,235 | 1,735 | 0 | 0 | 172 |
| Financing Cash Flow | $109,680 | $1,735 | $1,653 | $1,541 | $172 |
| Beginning Cash Position | 15,953 | 41,070 | 41,070 | 41,070 | 45,671 |
| End Cash Position | 145,924 | 15,953 | 24,547 | 33,130 | 41,070 |
| Net Cash Flow | $129,971 | $-25,117 | $-16,523 | $-7,940 | $-4,601 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,313 | -33,215 | -25,139 | -16,448 | -32,006 |
| Capital Expenditure | -22 | N/A | -290 | -276 | N/A |
| Free Cash Flow | 20,291 | -33,215 | -25,429 | -16,724 | -32,006 |